News 2024/02/29 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 2024/02/14 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 2024/04/15 First BOOM Summit deemed a success The organizers of the BOOM Summit are describing the first edition as a success. In total, 500 experts exchanged their knowledge and expertise at...
News 2024/04/09 DESI project unveils groundbreaking 3D universe map with EPFL’s aid EPFL astrophysicists have contributed to creating the most detailed 3D map of the universe, tracing expansion over 11 billion years.
News 2024/04/17 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 2024/04/10 Empa researchers develop cellulose-based aerogel A laboratory at the Swiss Federal Laboratories for Materials Science and Technology (Empa) has developed an ultralight, biodegradable and printab...
News 2024/04/05 Drones navigate even dense forest Researchers at the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL) and the Swiss Federal Institute of Technology Zurich hav...
News 2024/04/04 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
Aktuell 2024/04/10 Empa-Forschende entwickeln Aerogel aus Cellulose Ein Labor der Eidgenössischen Materialprüfungs- und Forschungsanstalt (Empa) hat ein ultraleichtes, biologisch abbaubares und druckbares Aerogel ...
News 2024/03/13 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
Aktuell 2024/04/04 Galderma realisiert weltweit grössten Börsengang Die Kotierung an der Schweizer Börse hat Galderma knapp 2,3 Milliarden Franken eingebracht. Damit stellt das Pharmaunternehmen im ersten Quartal ...
Actualités 2024/04/17 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 2024/03/07 Jedsy cooperates with the TCS to insure drone deliveries Drone specialist Jedsy from the canton of St.Gallen has entered into a partnership with the Touring Club Switzerland (TCS) to insure drone delive...
Aktuell 2024/03/26 Zürcher Forschende machen Krebstherapie wieder wirksam Forschende der Universität Zürich und des Universitätsspitals Zürich haben herausgefunden, wie mutierte Blutkrebszellen wieder auf eine Immunther...
Actualités 2024/04/09 Le projet DESI dévoile une carte 3D inédite de l’univers avec l’aide de l’EPFL Des astrophysiciens de l’EPFL ont contribué à la création de la carte 3D la plus détaillée de l’univers, retraçant son expansion sur 11 milliards...
News 2024/02/23 UZH on the case of a cause of dementia A team from the University of Zurich (UZH) has developed an innovative cell culture model for nerve cells. This shows that there is a correlation...
News 2024/02/19 Solita opens new office in Zurich under its Intellishore brand Solita, the Finnish data analysis and strategic consulting firm, is opening an office in Zurich under its Danish brand Intellishore. Intellishore...
News 2024/01/12 Gilde Healthcare acquires majority stake in Swiss Dental Solutions Gilde Healthcare is the new majority shareholder of Swiss Dental Solutions AG, which specializes in biological dentistry. Founder and former owne...